NPI was founded by a world — class leader in herbal medicine, and we have a world — class R&D team with a wealth of experience in drug development and expertise in complementary and alternative medicine research. From the beginning, we have been committed to developing novel botanical products that are validated by modern technology as FDA approved botanical drugs. Additionally, when feasible, we leverage our state-of-the-art drug discovery and development capabilities to identify and further develop single molecules responsible for the therapeutic effects of certain herbal medicines.
While we work on this rich and diversified portfolio of products in the R&D pipeline, several products are being developed into dietary supplements because of their undeniable health benefits, as demonstrated in pre-clinical and clinical settings. The herbal ingredients have also been used safely for hundreds if not thousands of years. Many patients are desperately waiting for alternatives to the prevailing treatment regimen, if there is any. We are providing these patients access to some of the proven and safe botanical products in the form of dietary supplements, under the overarching brand DR.LEE+TCM. Essentially we are expediting the availability of these herbal medicines, while cautioning customers about all of the potential drawbacks that can be ascribed to dietary supplements.
At present, two drugs are in Phase II and two are in Phase I clinical trials, and a number of early
phase botanicals are being investigated. You are welcome to find out more about our R&D effort via the NPI website.